FinBoss.io
CSEN
  • Crypto prices
  • Liquidation War
  • Crypto tools
  • Bitcoin on-chain
  • US macro
  • US stocks
    • Largest US stocks
    • Stock screener
    • Earnings calendar
    • Insider trading
    • Market heatmap
  • Markets
  • Tools
  • Guides
  • FinBot
FinBoss.io
Crypto prices
Liquidation War
Crypto tools
Altcoin Season Index
Big players (on-chain)
Bitcoin halving countdown
Bear market radar
Bitcoin on-chain
Hashrate
Mining difficulty
Mining pools
Mempool and fees
On-chain activity
MVRV and NUPL
SOPR
Holders
Supply in profit
Rainbow Chart
Fair value
Pi Cycle Top
US macro
FedWatch
Interest rates
Treasury yields
Inflation
Liquidity and Bitcoin
Business cycle
US stocks
Largest US stocks
Stock screener
Earnings calendar
Insider trading
Market heatmap
Markets
Stock indices
Commodities
Forex rates
Bear market radar
Famous investors' portfolios
Tools
Dashboards
Investor dashboardTrader dashboardBeginner dashboard
Calculators
Compound interestDCA calculatorDrawdown recovery
Compare
BrokersCrypto exchanges
Přehled sekce Tools →
Guides
FinBot
CSEN
Home
Stocks
Agilon Health Inc
AG

Agilon Health Inc

AGLNASDAQ

Stock · Data from SEC EDGAR 13F · Held by 5 of 87 tracked investors

$90.65
▲ 0.34%
Famous investorshold 5buying 0selling 0
Price (USD)
$90.65
Market cap
$1.5B
P/E ratio
–
Tracked investors holding
5 of 87
Next earnings
4 Nov 2026

Agilon Health Inc at a glance

An overview of the financial statements, in plain language. Switch to the advanced view for charts.

FinBoss score
49out of 100
  • Valuation34
  • Growth85
  • Profitability23
  • Quality20
  • Debt100
  • Stability33
In its favour
  • ✓It has more cash than debt.
  • ✓Revenue grew 35.4% a year over 3 years.
  • ✓The analysts' average target is 28% above the price.
What to watch
  • !The company is loss-making: net profit is negative.
  • !The stock is expensive: you pay 38.4 USD for 1 USD of annual earnings.

The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.

Is the stock expensive?

Fairly expensive

The company has no earnings, so the P/E cannot be calculated.

P/E
–
P/S
0.3×
EV/EBITDA
-5.7×

Is the company growing?

Growing
22
23
24
25

Revenue over 3 years grew 35.4% a year. Last year 7.2%.

Does it make money?

Loss-making
  • Cost of sales 103

Revenue and net profit (USD B)

Margins (% of revenue)

Free cash flow and capex (USD B)

Cash and debt (USD B)

Earnings per share (EPS, USD)

Latest quarters (USD B)

Earnings results

QuarterReportedEPSAnalyst estimateSurprise
Jun 20265 Aug 20261.040.06+1,633.3%
Mar 20266 May 20261.801.13+59.3%
Dec 202525 Feb 2026-11.50-6.75-70.4%
Sep 20254 Nov 2025-6.75-4.50-50%

EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.

Chart AGL

Insider purchases

last 90 days, SEC Form 4
Loading insider trades…

Which investors hold this stock

5
HE
Henry Ellenbogen
Durable Capital Partners
0.46%$47,228,010New position
CA
Cliff Asness
AQR Capital Management
0.03%$74,226,574▼ -29%
JS
Jim Simons
Renaissance Technologies
0.02%$16,314,297▲ +2.1%
PT
Paul Tudor Jones
Tudor Investment Corp
0.01%$3,787,312▲ +9.6%
JG
Joel Greenblatt
Gotham Asset Management
0%$607,389New position

Frequently asked questions

How much is Agilon Health Inc (AGL) stock?

Agilon Health Inc shares trade at $90.65, +0.34% over the last trading day. The price is delayed.

What is the market cap of Agilon Health Inc?

The market cap of Agilon Health Inc is about $1.5B.

Which big investors hold Agilon Health Inc?

According to the latest 13F filings, 5 of 87 tracked investors hold Agilon Health Inc, for example Henry Ellenbogen, Cliff Asness, Jim Simons.

When will Agilon Health Inc report its next results?

The next earnings report of Agilon Health Inc is expected on 4 Nov 2026.

Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.

© 2026 FinBoss.io. All rights reserved.

How we make moneyTerms of usePrivacy policyCookie policy

Disclaimer: the information on this site is for general information only and is not investment or financial advice. Investing involves risk, and cryptocurrencies are especially volatile. Past performance does not guarantee future results. Some links are affiliate links and are marked as ads.

  • Research 0.0
  • Operations and selling 4.5
  • Taxes and other 0.0
  • Net profit -6.6
  • Out of 100 USD of revenue, -6.6 USD is left as net profit.

    Is it financially healthy?

    Yes
    Cash
    186M USD
    Debt
    33M USD
    Free CF
    -146M USD

    It has more cash than debt.

    Does it pay a dividend?

    No dividend

    The company pays no dividend. It reinvests the money or holds it.

    What do analysts expect?

    Buy
    Average target
    115.83 USD
    Vs price
    +28%

    12 analysts. Their opinion is not a recommendation by FinBoss.io.

    Which big investors hold it?

    5 of 87

    Among the tracked investors, Henry Ellenbogen, Cliff Asness, Jim Simons and others hold the stock according to 13F filings.

    Ratios

    P/E
    –
    Forward P/E
    38.4×
    P/B
    6.7×
    P/S
    0.3×
    PEG
    –
    EV/EBITDA
    -5.7×
    Gross margin
    0.2%
    Operating margin
    1.3%
    Net margin
    -3.9%
    ROE
    -78.9%
    ROA
    -9.6%
    Debt / equity
    0.1×
    Current ratio
    1.1×
    Revenue growth
    7.2%
    Earnings growth
    –
    Beta
    3.00
    Dividend
    0.00%
    Payout ratio
    –